Edison Talks: Interview with Evan Jones, CEO of OpGen

Published on 25-11-2019 13:21:15

In this episode of Edison Talks, Maxim Jacobs, Edison’s director of research for North America, has an in-depth discussion with Evan Jones, the CEO of OpGen. Topics include OpGen’s products and the company’s focus on revolutionising the identification and treatment of bacterial infections, as well as the announced merger with Curetis.

00:50 Overview of OpGen
04:05 The benefits of using OpGen’s diagnostics versus current tests
05:57 The size of OpGen’s target market
13:21 OpGen’s merger with Curetis
19:44 Timing for the approval of products in development
25:50 Summary of upcoming catalysts

Share this with friends and colleagues